[Ablative strategy: a definite treatment for cardiac arrhythmias?]
Related Experiment Video
Updated: Aug 24, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Mélèze Hocini1, Jean-Luc Pasquié, Pierre Jaïs
1Service de cardiologie, Hôpital cardiologique du Haut-Levêque, 33604 Pessac Cedex. jacques.clementy@chu-bordeaux.fr
Abstract:
The development of radiofrequency catheter ablation has dramatically changed the therapeutic approach of cardiac arrhythmias. All atrial rhythm disturbances are now amenable to ablative strategy. Ablation has become the first-line therapy for atrial flutter. Atrial fibrillation, a major factor of morbidity and mortality, is now a target for this radical treatment. Ablation of pulmonary vein foci, eventually associated to atrial linear lesions, raises the possibility of suppressing atrial fibrillation. The success rate is now as high as 70 to 85%, depending on the form of atrial fibrillation. For atrioventricular reentrant tachycardia either nodal or over an accessory pathway, ablation is the reference treatment with success rates of 99%. All symptomatic Wolff-Parkinson-White syndromes can be definitely cured by this technique. At the ventricular level, the procedures are often more complexes, due to advanced cardiomyopathy. However, most of sustained ventricular tachycardias can be cured by ablation. The success rates are somewhat lower (about 80%). The challenge for the next years is ablation of premature ventricular beats initiating ventricular fibrillation. The technique is also improving from day-to-day (88% success rate) and makes rise the hope of curing sudden death.
More Related Videos
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
10:46Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...